Project 4: Neuroprotection and neuroinflammation induced by the complement proteins and receptors In order to increase the successful identification of novel therapeutic targets for degenerative disorders commonly seen in the elderiy, the interrelations between new discoveries in genetics (GWAS identified risk association genes), cell biology (autophagy), immunology (inflammasomes) and neurobiology must be delineated using a combination of experimental approaches. One rapidly emerging area is the link between the immune system and cellular homeostasis in neurobiological systems, consistent with a role for the immune system components in normal and pathological brain function. The complement system is a powerful effector mechanism of the innate immune system that contributes to protection from infection and resolution of injury. Complement component deposition has been associated with Alzheimer's disease (AD), macular degeneration, Parkinson's disease and other age-related neurodegenerative disorders. While the activation of the complement cascade may be detrimental in these diseases, C l q , the initiator molecule of the classical complement pathway, has anti-inflammatory effects in the absence of the other components of the complement system. Unexpectedly, it has become apparent that in the brain C l q synthesis is induced in response to a variety of insults and injury initially in the absence of synthesis of other complement components. In addition, our lab made the novel observation that in vitro C l q improves neuronal survival under nutrient stressed conditions and suppresses amyloid beta-induced neuronal death suggesting that C l q may have a neuroprotective role. This novel neuroprotection triggered by C l q was associated with induction of expression of neuronal genes which if suppressed abrogated the C l q neuroprotective effects. Here we will collaborate with other members of the Program Project to identify the mechanisms of this C l q neuroprotection/survival, determine if this coordinates with a GWAS identified risk polymorphism in CRI, and create new animal models to elucidate the significance of this pathway in in vivo models of neurodegenerative diseases in aging populations. The molecular delineation of this novel pathway should uncover a number of potential therapeutic targets which have not been explored which can then be translated into innovative strategies (perhaps in combination with other therapeutic targets) in the clinic for the enhancement of neuron survival to improve the quality of life for individuals suffering from neurodegenerative or neurodevelopmental disorders.

Public Health Relevance

This project will identify key signaling pathways and molecular interactions that are required for a novel neuroprotection mechanism discovered in our laboratory and determine if this pathway improves neuronal survival in an animal model of Alzheimer's Disease (AD). In a complementary approach the biological basis of the AD risk association of a polymorphism in an immune regulatory protein, CRI, will be determined. These results will provide the first step in design of novel pharmacologic interventions for degenerative diseases in humans.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Irvine
United States
Zip Code
Spangenberg, Elizabeth E; Lee, Rafael J; Najafi, Allison R et al. (2016) Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. Brain 139:1265-81
Passos, Giselle F; Kilday, Kelley; Gillen, Daniel L et al. (2016) Experimental hypertension increases spontaneous intracerebral hemorrhages in a mouse model of cerebral amyloidosis. J Cereb Blood Flow Metab 36:399-404
Hatami, Asa; Monjazeb, Sanaz; Glabe, Charles (2016) The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils. J Alzheimers Dis 50:517-25
Abbasi, Asghar; de Paula Vieira, Rodolfo; Bischof, Felix et al. (2016) Sex-specific variation in signaling pathways and gene expression patterns in human leukocytes in response to endotoxin and exercise. J Neuroinflammation 13:289
Acharya, Munjal M; Green, Kim N; Allen, Barrett D et al. (2016) Elimination of microglia improves cognitive function following cranial irradiation. Sci Rep 6:31545
Marsh, Samuel E; Abud, Edsel M; Lakatos, Anita et al. (2016) The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A 113:E1316-25
Linnartz-Gerlach, Bettina; Schuy, Christine; Shahraz, Anahita et al. (2016) Sialylation of neurites inhibits complement-mediated macrophage removal in a human macrophage-neuron Co-Culture System. Glia 64:35-47
Zhang, Liang; Trushin, Sergey; Christensen, Trace A et al. (2016) Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease. Sci Rep 6:18725
Snigdha, Shikha; Prieto, G Aleph; Petrosyan, Arpine et al. (2016) H3K9me3 Inhibition Improves Memory, Promotes Spine Formation, and Increases BDNF Levels in the Aged Hippocampus. J Neurosci 36:3611-22
Fonseca, Maria I; Chu, Shuhui; Pierce, Aimee L et al. (2016) Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function. PLoS One 11:e0149792

Showing the most recent 10 out of 254 publications